VCIM
Velan Capital Investment Management Portfolio holdings
AUM
$99.9M
This Quarter Return
+9.6%
1 Year Return
+37.46%
3 Year Return
+659.14%
5 Year Return
–
10 Year Return
–
AUM
$108M
AUM Growth
+$108M
(-10%)
Cap. Flow
-$974K
Cap. Flow
% of AUM
-0.9%
Top 10 Holdings %
Top 10 Hldgs %
79.92%
Holding
31
New
4
Increased
4
Reduced
3
Closed
6
Top Buys
| 1 |
RDUS
Radius Health, Inc.
RDUS
|
$10.1M |
| 2 |
ATRS
Antares Pharma, Inc.
ATRS
|
$5.52M |
| 3 |
OPTN
OptiNose
OPTN
|
$4.94M |
| 4 |
TELA Bio
TELA
|
$1.76M |
| 5 |
Viatris
VTRS
|
$1.09M |
Top Sells
| 1 |
Lantheus
LNTH
|
$16.7M |
| 2 |
NMTR
9 Meters Biopharma, Inc. Common Stock
NMTR
|
$4.24M |
| 3 |
MEI Pharma
MEIP
|
$2M |
| 4 |
Curis
CRIS
|
$1.19M |
| 5 |
NKGN
NKGen Biotech, Inc. Common Stock
NKGN
|
$836K |
Sector Composition
| 1 | Healthcare | 85.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Curis
CRIS
$21.1M
| – | – |
-250,000
| Closed | -$1.19M |
|
|
27
MEI Pharma
MEIP
$160M
| – | – |
-747,768
| Closed | -$2M |
|
28
enVVeno Medical
NVNO
$15.4M
| – | – |
-74,478
| Closed | -$491K |
|
29
Xeris Biopharma Holdings
XERS
$1.26B
| – | – |
0
| – | – |
|
|
ITCI
30
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| – | – |
0
| – | – |
|
|
NKGN
31
DELISTED
NKGen Biotech, Inc. Common Stock
NKGN
| – | – |
-86,506
| Closed | -$836K |
|